Cost-effectiveness of eptifibatide in patients undergoing planned coronary stenting: Results from the ESPRIT trial

被引：0
|
作者：
Cohen, DJ
Cosgrove, RS
Berezin, RH
O'Shea, J
Kitt, MM
Gilchrist, I
Mark, DB
Tcheng, JE
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Harvard Clin Res Inst, Boston, MA USA
[3] Duke Clin Res Inst, Durham, NC USA
[4] Cor Therapeut, San Francisco, CA USA
[5] Penn State Univ, Coll Med, College Stn, PA USA
来源：
CIRCULATION | 2001年 / 104卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1841
引用
收藏
页码：386 / 387
页数：2
相关论文
共 50 条
  • [11] Cost-effectiveness of distal protection for patients undergoing vein graft intervention: Results from the SAFER trial
    Cohen, DJ
    Murphy, SA
    Lavelle, T
    Berezin, RH
    Baim, DS
    Feldman, R
    Kuntz, RE
    CIRCULATION, 2001, 104 (17) : 777 - 777
  • [12] Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting
    Neumann, FJ
    Hochholzer, W
    Pogatsa-Murray, G
    Schömig, A
    Gawaz, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (05) : 1323 - 1328
  • [13] Costs and Cost-Effectiveness of Carotid Stenting versus Endarterectomy for Patients at Increased Surgical Risk: Results From the SAPPHIRE Trial
    Mahoney, Elizabeth M.
    Greenberg, Dan
    Lavelle, Tara A.
    Natarajan, Amy
    Berezin, Ronna
    Ishak, K. Jack
    Caro, Jamie J.
    Yadav, Jay S.
    Gray, William A.
    Wholey, Mark H.
    Cohen, David J.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2011, 77 (04) : 463 - 472
  • [14] Eptifibatide (Integrilin®) in coronary stent implantation:: long-term results of the ESPRIT trial
    O'Shea, JC
    Cohen, EA
    Buller, CE
    Hafley, G
    Kitt, MM
    Lorenz, TJ
    Califf, RM
    Tcheng, JE
    Madan, M
    Cohen, DJ
    EUROPEAN HEART JOURNAL, 2001, 22 : 121 - 121
  • [15] Eptifibatide (Integrilin®) in coronary stent implantation:: Long-term results of the ESPRIT trial
    Tcheng, JE
    Cohen, EA
    Buller, CE
    Cohen, DJ
    Madan, M
    Kitt, MM
    Cantor, WJ
    Lorenz, TJ
    Hafley, G
    Greenberg, S
    O'Shea, JC
    CIRCULATION, 2001, 104 (17) : 94 - 94
  • [16] Evaluation of the cost-effectiveness of coronary stenting: A societal perspective
    Cohen, DJ
    AMERICAN HEART JOURNAL, 1999, 137 (05) : S133 - S137
  • [17] Outpatient transradial coronary stenting: Implications for cost-effectiveness
    Cohen, DJ
    JOURNAL OF INVASIVE CARDIOLOGY, 1996, 8 : D36 - D39
  • [18] COST-EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES AND PLANNED PCI: RESULTS FROM THE TRITON-TIMI 38 TRIAL FROM THE GERMAN PERSPECTIVE
    Mahoney, E. M.
    Wang, K.
    McCollam, P. L.
    Schmitt, C.
    Cohen, D. J.
    VALUE IN HEALTH, 2009, 12 (07) : A328 - A329
  • [19] Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial
    Tcheng, JE
    O'Shea, JC
    Cohen, EA
    Pacchiana, CM
    Kitt, MM
    Lorenz, TJ
    Greenberg, S
    Strony, J
    Califf, RM
    Buller, C
    Cantor, WJ
    Joseph, DM
    Kitt, MM
    Lincoff, AM
    Madan, M
    Popma, J
    Teirstein, P
    Cohen, E
    Balleza, L
    Parsons, P
    Lui, H
    Young, J
    Fox, R
    Labinaz, M
    Jelley, J
    Williams, J
    Cohen, D
    Trovato, M
    Smith, J
    Henry, P
    Chisholm, R
    O'Donnell, D
    Talley, JD
    Pacheco, R
    Timmis, S
    Muraka, A
    Mann, T
    Cubeddu, G
    Tannenbaum, M
    Greene, J
    Santoian, E
    Wash, M
    Sheldon, S
    Pronesti, L
    Jain, A
    Alonzo, M
    Seidelin, P
    Richards, J
    Lopez, M
    Dittenber, R
    LANCET, 2000, 356 (9247): : 2037 - 2044
  • [20] High-dose eptifibatide (Integrilin®) in elective coronary stent implantation:: results of the ESPRIT trial
    Califf, RM
    Cohen, EA
    Buller, CE
    Lincoff, AM
    Popma, JJ
    Teirstein, PS
    Pacchiana, CM
    O'Shea, JC
    Lorenz, TJ
    Tcheng, J
    EUROPEAN HEART JOURNAL, 2000, 21 : 146 - 146
12345